What changed in Cardinal Health, Inc.'s latest annual report
In the year ended 30 Jun 2026, Cardinal Health, Inc.'s revenue rose 14.2% to USD 254.25bn, from USD 222.58bn; net income rose 9.8% to USD 1.71bn, from USD 1.56bn; cash and cash equivalents rose 25.3% to USD 4.86bn, from USD 3.87bn.
Year ended 30 Jun 2026. Source: 10-K filed 11 Aug 2026, read it on SEC EDGAR.
USD 222.58bn to USD 254.25bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 222.58bn | 254.25bn | Up 14.2% |
| Net income | 1.56bn | 1.71bn | Up 9.8% |
| Total assets | 53.12bn | 57.30bn | Up 7.9% |
| Cash and cash equivalents | 3.87bn | 4.86bn | Up 25.3% |
| Shareholders' equity | -2.78bn | -2.88bn | Not comparable |
Questions people ask
Did Cardinal Health, Inc.'s revenue grow last year?
Revenue grew 14.2%, from USD 222.58bn to USD 254.25bn in the year ended 30 Jun 2026.
Is Cardinal Health, Inc. profitable?
Yes. Net income was USD 1.71bn in the year ended 30 Jun 2026. The year before: USD 1.56bn.
How much cash and debt does Cardinal Health, Inc. have?
At its latest year end (30 Jun 2026), Cardinal Health, Inc. reported cash and cash equivalents of USD 4.86bn.
Where do these numbers come from?
From Cardinal Health, Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Cardinal Health, Inc.?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- McKESSON CORPORATIONNet income up 44.5%
- Cencora, Inc.Shareholders' equity up 133.5%